BofA Securities issued a research report keeping rating at Buy on ALI HEALTH (00241.HK) -0.010 (-0.221%) Short selling $529.14M; Ratio 49.369% on its improving platform business momentum and expanding profitability. The broker believed that the upside catalysts for ALI HEALTH's share price include social medical insurance payment through online channel, benefit from Taobao's traffic growth and shopping scenario expansion. Therefore, BofA Securities added its target price for ALI HEALTH from $5.2 to $5.5.Related NewsCICC Raises ALI HEALTH (00241.HK) TP by 17% to $5.5 as Results Largely in LineALI HEALTH's FY2025 revenues rose by 13% YoY, slightly beating forecast, mainly driven by accelerated growth in its direct sales business in 2HFY2025, according to the broker. Non-GAAP net profit for the year was in line with market consensus, but below BofA Securities' prediction, due to higher selling and marketing expenses.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-22 16:25.)